Vimarsana
Biggest News Aggregation in the World

Page 10 - Development Milestones News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Milestones. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Milestones Today - Breaking & Trending Today

Asia Broadband Proprietary Cryptocurrency Exchange Development Update and Distinctive Features - Vimarsana News

Asia Broadband Proprietary Cryptocurrency Exchange Development Update and Distinctive Features

LAS VEGAS, June 03, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has continued to achieve numerous development milestones in the initial months of building its proprietary cryptocurrency exchange (the “Exchange”). Subsequent to the recent launch of the Company’s AABBG gold-backed token, created with developer Core State Holdings, Corp. (CSHC), AABB’s own proprietary cryptocurrency Exchange version of

Source: yahoo.com
Global microRNA 21 (MIR21) Drugs Development Market Report 2021: Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type - Vimarsana News

Global microRNA 21 (MIR21) Drugs Development Market Report 2021: Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type

Share this article Share this article ResearchAndMarkets.com's offering. microRNA 21 (MIR21) - Drugs in Development, 2021 provides in depth analysis on microRNA 21 (MIR21) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview o...

Global Therapeutic Landscape of Avian Influenza Drugs in Development 2021 - Vimarsana News

Global Therapeutic Landscape of Avian Influenza Drugs in Development 2021

Global Therapeutic Landscape of Avian Influenza Drugs in Development 2021 News provided by Share this article Share this article ResearchAndMarkets.com's offering. Avian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landscape. The report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action o...

BlueWave Solar Announces Milestone Achievements in Sustainable Energy - Vimarsana News

BlueWave Solar Announces Milestone Achievements in Sustainable Energy

BlueWave Solar Announces Milestone Achievements in Sustainable Energy Progress showcases efforts in protecting the planet by transforming access to renewable energy through solar development and community solar servicing News provided by Share this article Share this article BOSTON, March 16, 2021 /PRNewswire/ -- BlueWave Solar, a leading Boston-based solar and energy storage developer and community solar service provider, announced today recent milestone achievements and impacts of its work in clean energy development and community solar project servicing. As of the end of 2020, the company...

Parkinson's Disease: Global Therapeutic Development Analysis H2 2020 including Drug Profiles and Key Company Reviews - Vimarsana News

Parkinson's Disease: Global Therapeutic Development Analysis H2 2020 including Drug Profiles and Key Company Reviews

Share this article Share this article ResearchAndMarkets.com's offering. Report Highlights The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 11, 48, 62, 4, 224, 97 and 9 respectively. Similarly, the Universitie...